In contrast, Cyp11b1 showcases an amelioration of hypertension independent of its pathogenesis, as the responsible mutations appear in normotensive Dahl salt-resistant rats (DSR) [24]. This evidence concerns the gene CYP11B1 and hypertensive disorder.